Good MorningThe selloff in equities resumed on Thursday as traders brace for what could be an historic PCE price index. Although the index is expected to decelerate on a YOY basis it is expected to remain high and at a level that confirms the latest twist in the FOMC outlook. The twist is that the FOMC slowed the rate hike pace but upped its expectations for both inflation and peak interest rates.
Thursday’s candle is a warning to the market. Investors hoping for a Santa Claus Rally should be cautious. The market may rise next week simply because of a lack of volume and the "underlying bid". In this scenario, any upswing in prices will likely be met by selling that drives the index down to a new low Featured: Putin's "Violent Death" (The Oxford Club) 
|
Stocks | | |
As temperatures drop throughout the U.S., sunshine and warmth may seem like distant dreams. But for shareholders of top-performing solar-energy stocks such as Enphase Energy Inc. (NASDAQ: ENPH), SolarEdge Technologies Inc. (NASDAQ: SEDG), and First Solar Inc. (NASDAQ: FSLR), those brighter days ma... Read the Full Story |
|
From Our PartnersEverything is lining up perfectly for a historic gold bull run. One gold research firm says they've found the best way to get in, for less than $10. | | | | MORE here... |
|
Markets | | | Shares declined in Asia on Friday after a retreat on Wall Street driven by fears that strong economic data will lead the Federal Reserve to double down on its interest rate hikes to tame inflation.
Shanghai was flat while other major indexes declined. U.S. futures edged higher and oil... Read the Full Story |
|
Markets | | |
Well, it was fun while it lasted. Traders had some holiday fun with Palantir Technologies Inc. (NYSE: PLTR) stock a few days before the Christmas holiday. On December 21, PLTR shares went up 5% on the news that Palantir was awarded a multi-million deal with the United Kingdom's Ministry of De... Read the Full Story |
|
From Our PartnersLegendary Investor Paul Tudor Jones Predicts "Violent Death" for Putin.
Few people know this, but Putin just made the single biggest mistake of his life. It's not invading Ukraine... but it could have a profound effect on world markets. | | | | A market expert breaks down the opportunity here. |
|
Markets | | | Worries about higher interest rates are pummeling Wall Street Thursday, and the Dow Jones Industrial Average is tumbling more than 700 points, following some stronger-than-expected reports on the U.S. economy.
The S&P 500 was 2.7% lower in afternoon trading, bringing Wall Street’... Read the Full Story |
|
Stocks | | |
You may think of equipment makers Caterpillar Inc. (NYSE: CAT) and Deere & Company (NYSE: DE) as literally moving slowly, but these heavy equipment stocks outran the S&P 500 throughout 2022 and pulled into a sprint to end the year.
Despite its name, Caterpillar hasn’t exactly been c... Read the Full Story |
|
From Our PartnersDid you know... low-priced, or "penny," stocks offer a great way to make money regardless of the direction of the markets as a whole. And these top 4 penny stocks are poised to soar... The best part is... they are trading for $5 a share or less. | | | | Click Here for the Names & Ticker Symbol. |
|
Markets | | |
On a day when the broader market soared over 500 points, Lucid Group, Inc. (NASDAQ: LCID) was a notable laggard. Shares of LCID stock fell by less than one percent. But it continues the downward trend for the stock, down 30% in the last month and over 80% in 2022.
One sore spot for investor... Read the Full Story |
|
Markets | | | Shares rose in Europe on Friday after a retreat in Asia ahead of updates on U.S. consumer spending and durable goods orders.
Benchmarks climbed in London and Paris but fell in Hong Kong, Tokyo and Seoul. Oil prices surged more than $1 a barrel.
Japan reported its core... Read the Full Story |
|
Markets | | | Wall Street is falling sharply Thursday, giving back its gains from the last two days, after better-than-expected data on the economy fueled worries about higher interest rates.
Usually good news on the economy would be good for markets, particularly when worries about a potential rec... Read the Full Story |
|
Markets | | | Wall Street is falling Thursday, giving back its gains from the last two days, after better-than-expected data on the economy fueled worries about higher interest rates.
Usually good news on the economy would be good for markets, particularly when worries about a potential recession a... Read the Full Story |
|
Markets | | |
Mullen Automotive, Inc. (NASDAQ: MULN) stock is up nearly 4% (3.95%) in midday trading on news that the company's first I-GO™ vehicles have arrived in Europe. The I-GO™ is an urban commercial delivery vehicle purposefully designed to meet the space constraints in dense cities thro... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma. It also develops lifileucel in combination with pembrolizumab to treat frontline advanced melanoma patients; LN-145 for the treatment of non-small cell lung cancer (NSCLC) and solid tumor cancers; IOV-4001, which is in Phase 1/2 IOV-GM1-201 clinical trial, for the treatment of NSCLC; and lifileucel for gynecological cancers. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. | | View Today's Stock Pick |
|
